{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T08:23:21Z","timestamp":1776759801219,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81772555"],"award-info":[{"award-number":["81772555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81802352"],"award-info":[{"award-number":["81802352"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"national natural science foundation of china","doi-asserted-by":"publisher","award":["81902428"],"award-info":[{"award-number":["81902428"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"national science foundation for distinguished young scholars of china","award":["81625016"],"award-info":[{"award-number":["81625016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Extensive studies have demonstrated the pivotal roles of circular RNAs (circRNAs) in the occurrence and development of different human cancers. However, the expression and regulatory roles of circRNAs in pancreatic ductal adenocarcinoma (PDAC) are unclear.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>CircEYA3 was explored based on Gene Expression Omnibus (GEO) dataset analysis. qRT-PCR was applied to determine the expression of circRNAs, miRNAs and mRNAs in PDAC cells and tissues. The biological roles of circEYA3 in vitro and in vivo were determined by performing a series of functional experiments. Further, dual luciferase reporter, fluorescence in situ hybridization (FISH), RNA pull-down assays, and RNA immunoprecipitation (RIP) assays were used to confirm the interaction of circEYA3 with miR-1294.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>CircEYA3 was elevated in PDAC tissues and cells, and a higher level of circEYA3 was significantly associated with a poorer prognosis in patients with PDAC. Functionally, circEYA3 increased energy production via ATP synthesis to promote PDAC progression in vitro and in vivo. Mechanistically, circEYA3 functions as an endogenous miR-1294 sponge to elevate c-Myc expression, thus exerting its oncogenic functions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CircEYA3 promotes the progression of PDAC through the miR-1294\/c-Myc signalling axis, and circEYA3 may be an efficient molecular therapeutic target in PDAC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12943-021-01400-z","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T06:02:59Z","timestamp":1629525779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Circular RNA CircEYA3 induces energy production to promote pancreatic ductal adenocarcinoma progression through the miR-1294\/c-Myc axis"],"prefix":"10.1186","volume":"20","author":[{"given":"Zeyin","family":"Rong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingcai","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianjun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0578-7589","authenticated-orcid":false,"given":"Chen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"issue":"6","key":"1400_CR1","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1053\/j.gastro.2013.01.078","volume":"144","author":"AS Paulson","year":"2013","unstructured":"Paulson AS, Tran Cao HS, Tempero MA, Lowy AM. Therapeutic advances in pancreatic cancer. Gastroenterology. 2013;144(6):1316\u201326. https:\/\/doi.org\/10.1053\/j.gastro.2013.01.078.","journal-title":"Gastroenterology."},{"issue":"6","key":"1400_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41575-018-0005-x","volume":"15","author":"JP Neoptolemos","year":"2018","unstructured":"Neoptolemos JP, Kleeff J, Michl P, Costello E, Greenhalf W, Palmer DH. Therapeutic developments in pancreatic cancer: current and future perspectives. Nat Rev Gastroenterol Hepatol. 2018;15(6):333\u201348. https:\/\/doi.org\/10.1038\/s41575-018-0005-x.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10039","key":"1400_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","volume":"388","author":"T Kamisawa","year":"2016","unstructured":"Kamisawa T, Wood LD, Itoi T, Takaori K. Pancreatic cancer. Lancet. 2016;388(10039):73\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(16)00141-0.","journal-title":"Lancet."},{"issue":"1","key":"1400_CR4","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-017-0663-2","volume":"16","author":"S Meng","year":"2017","unstructured":"Meng S, Zhou H, Feng Z, Xu Z, Tang Y, Li P, et al. CircRNA: functions and properties of a novel potential biomarker for cancer. Mol Cancer. 2017;16(1):94. https:\/\/doi.org\/10.1186\/s12943-017-0663-2.","journal-title":"Mol Cancer"},{"issue":"7441","key":"1400_CR5","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333\u20138. https:\/\/doi.org\/10.1038\/nature11928.","journal-title":"Nature."},{"issue":"5","key":"1400_CR6","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf A, Stottmeister C, Gla\u017ear P, Jens M, Pino N, Giusti S, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870\u201385. https:\/\/doi.org\/10.1016\/j.molcel.2015.03.027.","journal-title":"Mol Cell"},{"issue":"3","key":"1400_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.molcel.2018.06.034","volume":"71","author":"X Li","year":"2018","unstructured":"Li X, Yang L, Chen LL. The biogenesis, functions, and challenges of circular RNAs. Mol Cell. 2018;71(3):428\u201342. https:\/\/doi.org\/10.1016\/j.molcel.2018.06.034.","journal-title":"Mol Cell"},{"issue":"1","key":"1400_CR8","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1038\/s41467-019-11162-4","volume":"10","author":"Z Cheng","year":"2019","unstructured":"Cheng Z, Yu C, Cui S, Wang H, Jin H, Wang C, et al. circTP63 functions as a ceRNA to promote lung squamous cell carcinoma progression by upregulating FOXM1. Nat Commun. 2019;10(1):3200.","journal-title":"Nat Commun"},{"issue":"1","key":"1400_CR9","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12943-020-01203-8","volume":"19","author":"Z Luo","year":"2020","unstructured":"Luo Z, Rong Z, Zhang J, Zhu Z, Yu Z, Li T, et al. Circular RNA circCCDC9 acts as a miR-6792-3p sponge to suppress the progression of gastric cancer through regulating CAV1 expression. Mol Cancer. 2020;19(1):86. https:\/\/doi.org\/10.1186\/s12943-020-01203-8.","journal-title":"Mol Cancer"},{"issue":"1","key":"1400_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12943-020-1134-8","volume":"19","author":"X Jian","year":"2020","unstructured":"Jian X, He H, Zhu J, Zhang Q, Zheng Z, Liang X, et al. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer. 2020;19(1):20. https:\/\/doi.org\/10.1186\/s12943-020-1134-8.","journal-title":"Mol Cancer"},{"issue":"1","key":"1400_CR11","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12943-020-01269-4","volume":"19","author":"S Shen","year":"2020","unstructured":"Shen S, Yao T, Xu Y, Zhang D, Fan S, Ma J. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19(1):151. https:\/\/doi.org\/10.1186\/s12943-020-01269-4.","journal-title":"Mol Cancer"},{"issue":"1","key":"1400_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ccell.2019.12.007","volume":"37","author":"D Hanniford","year":"2020","unstructured":"Hanniford D, Ulloa-Morales A, Karz A, Berzoti-Coelho MG, Moubarak RS, Sanchez-Sendra B, et al. Epigenetic silencing of CDR1as drives IGF2BP3-mediated melanoma invasion and metastasis. Cancer Cell. 2020;37(1):55\u201370 e15. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.007.","journal-title":"Cancer Cell"},{"issue":"1","key":"1400_CR13","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-020-01196-4","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L, et al. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p\/MET\/Akt axis. Mol Cancer. 2020;19(1):83. https:\/\/doi.org\/10.1186\/s12943-020-01196-4.","journal-title":"Mol Cancer"},{"issue":"1","key":"1400_CR14","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12943-021-01333-7","volume":"20","author":"P Shen","year":"2021","unstructured":"Shen P, Yang T, Chen Q, Yuan H, Wu P, Cai B, et al. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing. Mol Cancer. 2021;20(1):51. https:\/\/doi.org\/10.1186\/s12943-021-01333-7.","journal-title":"Mol Cancer"},{"issue":"6","key":"1400_CR15","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.7150\/thno.56174","volume":"11","author":"Z Rong","year":"2021","unstructured":"Rong Z, Xu J, Shi S, Tan Z, Meng Q, Hua J, et al. Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics. 2021;11(6):2755\u201369. https:\/\/doi.org\/10.7150\/thno.56174.","journal-title":"Theranostics."},{"issue":"8","key":"1400_CR16","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1158\/1535-7163.MCT-16-0050","volume":"15","author":"M Wirth","year":"2016","unstructured":"Wirth M, Mahboobi S, Kr\u00e4mer OH, Schneider G. Concepts to target MYC in pancreatic Cancer. Mol Cancer Ther. 2016;15(8):1792\u20138. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0050.","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1400_CR17","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1158\/0008-5472.CAN-18-1968","volume":"79","author":"C Liang","year":"2019","unstructured":"Liang C, Shi S, Liu M, Qin Y, Meng Q, Hua J, et al. PIN1 maintains redox balance via the c-Myc\/NRF2 Axis to counteract Kras-induced mitochondrial respiratory injury in pancreatic Cancer cells. Cancer Res. 2019;79(1):133\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-1968.","journal-title":"Cancer Res"},{"issue":"5","key":"1400_CR18","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1136\/gutjnl-2018-317163","volume":"69","author":"C Liang","year":"2020","unstructured":"Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q, et al. Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2020;69(5):888\u2013900. https:\/\/doi.org\/10.1136\/gutjnl-2018-317163.","journal-title":"Gut."},{"issue":"1","key":"1400_CR19","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s13045-019-0837-z","volume":"12","author":"K Ogawa","year":"2019","unstructured":"Ogawa K, Lin Q, Li L, Bai X, Chen X, Chen H, et al. Aspartate \u03b2-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. J Hematol Oncol. 2019;12(1):144. https:\/\/doi.org\/10.1186\/s13045-019-0837-z.","journal-title":"J Hematol Oncol"},{"issue":"9","key":"1400_CR20","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.7150\/thno.40566","volume":"10","author":"Q Meng","year":"2020","unstructured":"Meng Q, Liang C, Hua J, Zhang B, Liu J, Zhang Y, et al. A miR-146a-5p\/TRAF6\/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 2020;10(9):3967\u201379. https:\/\/doi.org\/10.7150\/thno.40566.","journal-title":"Theranostics."},{"issue":"6","key":"1400_CR21","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/nar\/gkw027","volume":"44","author":"WW Du","year":"2016","unstructured":"Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44(6):2846\u201358. https:\/\/doi.org\/10.1093\/nar\/gkw027.","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"1400_CR22","doi-asserted-by":"publisher","first-page":"3950","DOI":"10.1158\/1078-0432.CCR-15-2380","volume":"22","author":"S Ji","year":"2016","unstructured":"Ji S, Qin Y, Liang C, Huang R, Shi S, Liu J, et al. FBW7 (F-box and WD repeat domain-containing 7) negatively regulates glucose metabolism by targeting the c-Myc\/TXNIP (Thioredoxin-binding protein) Axis in pancreatic Cancer. Clin Cancer Res. 2016;22(15):3950\u201360. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2380.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"1400_CR23","doi-asserted-by":"publisher","first-page":"7661","DOI":"10.3892\/mmr.2018.8827","volume":"17","author":"S Guo","year":"2018","unstructured":"Guo S, Xu X, Ouyang Y, Wang Y, Yang J, Yin L, et al. Microarray expression profile analysis of circular RNAs in pancreatic cancer. Mol Med Rep. 2018;17(6):7661\u201371. https:\/\/doi.org\/10.3892\/mmr.2018.8827.","journal-title":"Mol Med Rep"},{"issue":"6","key":"1400_CR24","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1159\/000453186","volume":"40","author":"H Li","year":"2016","unstructured":"Li H, Hao X, Wang H, Liu Z, He Y, Pu M, et al. Circular RNA expression profile of pancreatic ductal adenocarcinoma revealed by microarray. Cell Physiol Biochem. 2016;40(6):1334\u201344. https:\/\/doi.org\/10.1159\/000453186.","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"1400_CR25","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1158\/0008-5472.CAN-19-3268","volume":"80","author":"CH Wong","year":"2020","unstructured":"Wong CH, Lou UK, Li Y, Chan SL, Tong JH, To KF, et al. CircFOXK2 promotes growth and metastasis of pancreatic ductal adenocarcinoma by complexing with RNA-binding proteins and sponging MiR-942. Cancer Res. 2020;80(11):2138\u201349. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-3268.","journal-title":"Cancer Res"},{"issue":"1","key":"1400_CR26","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s13046-019-1436-0","volume":"38","author":"Y Chen","year":"2019","unstructured":"Chen Y, Li Z, Zhang M, Wang B, Ye J, Zhang Y, et al. Circ-ASH2L promotes tumor progression by sponging miR-34a to regulate Notch1 in pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res. 2019;38(1):466. https:\/\/doi.org\/10.1186\/s13046-019-1436-0.","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"1400_CR27","first-page":"291","volume":"8","author":"H Chen","year":"2018","unstructured":"Chen H, Liu L, Li X, Shi Y, Liu N. MicroRNA-1294 inhibits the proliferation and enhances the chemosensitivity of glioma to temozolomide via the direct targeting of TPX2. Am J Cancer Res. 2018;8(2):291\u2013301.","journal-title":"Am J Cancer Res"},{"issue":"24","key":"1400_CR28","doi-asserted-by":"publisher","first-page":"8582","DOI":"10.26355\/eurrev_201812_16621","volume":"22","author":"ZF Zhang","year":"2018","unstructured":"Zhang ZF, Li GR, Cao CN, Xu Q, Wang GD, Jiang XF. MicroRNA-1294 targets HOXA9 and has a tumor suppressive role in osteosarcoma. Eur Rev Med Pharmacol Sci. 2018;22(24):8582\u20138. https:\/\/doi.org\/10.26355\/eurrev_201812_16621.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"1400_CR29","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.26355\/eurrev_201905_17797","volume":"23","author":"W Pan","year":"2019","unstructured":"Pan W, Pang LJ, Cai HL, Wu Y, Zhang W, Fang JC. MiR-1294 acts as a tumor suppressor in clear cell renal cell carcinoma through targeting HOXA6. Eur Rev Med Pharmacol Sci. 2019;23(9):3719\u201325. https:\/\/doi.org\/10.26355\/eurrev_201905_17797.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1400_CR30","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbrc.2018.12.088","volume":"509","author":"Y Xu","year":"2019","unstructured":"Xu Y, Yao Y, Gao P, Cui Y. Upregulated circular RNA circ_0030235 predicts unfavorable prognosis in pancreatic ductal adenocarcinoma and facilitates cell progression by sponging miR-1253 and miR-1294. Biochem Biophys Res Commun. 2019;509(1):138\u201342. https:\/\/doi.org\/10.1016\/j.bbrc.2018.12.088.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1400_CR31","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1159\/000374056","volume":"36","author":"K Liu","year":"2015","unstructured":"Liu K, Li L, Rusidanmu A, Wang Y, Lv X. Down-regulation of MiR-1294 is related to dismal prognosis of patients with esophageal squamous cell carcinoma through elevating C-MYC expression. Cell Physiol Biochem. 2015;36(1):100\u201310. https:\/\/doi.org\/10.1159\/000374056.","journal-title":"Cell Physiol Biochem"},{"issue":"2","key":"1400_CR32","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.3892\/ol.2018.8967","volume":"16","author":"Z Wang","year":"2018","unstructured":"Wang Z, Yan J, Zou T, Gao H. MicroRNA-1294 inhibited oral squamous cell carcinoma growth by targeting c-Myc. Oncol Lett. 2018;16(2):2243\u201350. https:\/\/doi.org\/10.3892\/ol.2018.8967.","journal-title":"Oncol Lett"},{"issue":"9","key":"1400_CR33","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/15384047.2019.1617563","volume":"20","author":"YZ Wang","year":"2019","unstructured":"Wang YZ, An Y, Li BQ, Lu J, Guo JC. Research progress on circularRNAs in pancreatic cancer: emerging but promising. Cancer Biol Ther. 2019;20(9):1163\u201371. https:\/\/doi.org\/10.1080\/15384047.2019.1617563.","journal-title":"Cancer Biol Ther"},{"key":"1400_CR34","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.omtn.2019.12.028","volume":"20","author":"H Shi","year":"2020","unstructured":"Shi H, Li H, Zhen T, Dong Y, Pei X, Zhang X. hsa_circ_001653 Implicates in the Development of Pancreatic Ductal Adenocarcinoma by Regulating MicroRNA-377-Mediated HOXC6 Axis. Mol Ther Nucleic Acids. 2020;20:252\u201364.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"1","key":"1400_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41568-020-00306-0","volume":"21","author":"GJ Goodall","year":"2021","unstructured":"Goodall GJ, Wickramasinghe VO. RNA in cancer. Nat Rev Cancer. 2021;21(1):22\u201336. https:\/\/doi.org\/10.1038\/s41568-020-00306-0.","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"1400_CR36","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41419-018-0852-y","volume":"9","author":"RC Li","year":"2018","unstructured":"Li RC, Ke S, Meng FK, Lu J, Zou XJ, He ZG, et al. CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7\/HOXB13. Cell Death Dis. 2018;9(8):838. https:\/\/doi.org\/10.1038\/s41419-018-0852-y.","journal-title":"Cell Death Dis"},{"issue":"6","key":"1400_CR37","doi-asserted-by":"publisher","first-page":"e12521","DOI":"10.1111\/cpr.12521","volume":"51","author":"J Zhang","year":"2018","unstructured":"Zhang J, Hu H, Zhao Y, Zhao Y. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals. Cell Prolif. 2018;51(6):e12521. https:\/\/doi.org\/10.1111\/cpr.12521.","journal-title":"Cell Prolif"},{"key":"1400_CR38","doi-asserted-by":"publisher","first-page":"549982","DOI":"10.3389\/fonc.2020.549982","volume":"10","author":"F Jian","year":"2020","unstructured":"Jian F, Yangyang R, Wei X, Jiadan X, Na L, Peng Y, et al. The prognostic and predictive significance of circRNA CDR1as in tumor progression. Front Oncol. 2020;10:549982.","journal-title":"Front Oncol"},{"issue":"1","key":"1400_CR39","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1038\/s41467-020-18355-2","volume":"11","author":"LS Kristensen","year":"2020","unstructured":"Kristensen LS, Ebbesen KK, Sokol M, Jakobsen T, Korsgaard U, Eriksen AC, et al. Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory. Nat Commun. 2020;11(1):4551. https:\/\/doi.org\/10.1038\/s41467-020-18355-2.","journal-title":"Nat Commun"},{"key":"1400_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.canlet.2018.09.019","volume":"438","author":"AM Harrandah","year":"2018","unstructured":"Harrandah AM, Mora RA, Chan EKL. Emerging microRNAs in cancer diagnosis, progression, and immune surveillance. Cancer Lett. 2018;438:126\u201332. https:\/\/doi.org\/10.1016\/j.canlet.2018.09.019.","journal-title":"Cancer Lett"},{"issue":"5","key":"1400_CR41","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nbt.2890","volume":"32","author":"WR Jeck","year":"2014","unstructured":"Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453\u201361. https:\/\/doi.org\/10.1038\/nbt.2890.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1400_CR42","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/cas.14717","volume":"112","author":"TM Chang","year":"2021","unstructured":"Chang TM, Chu PY, Hung WC, Shan YS, Lin HY, Huang KW, et al. C-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation. Cancer Sci. 2021;112(1):243\u201353. https:\/\/doi.org\/10.1111\/cas.14717.","journal-title":"Cancer Sci"},{"issue":"14","key":"1400_CR43","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.1038\/s41388-018-0602-8","volume":"38","author":"Z Yang","year":"2019","unstructured":"Yang Z, Qu CB, Zhang Y, Zhang WF, Wang DD, Gao CC, et al. Dysregulation of p53-RBM25-mediated circAMOTL1L biogenesis contributes to prostate cancer progression through the circAMOTL1L-miR-193a-5p-Pcdha pathway. Oncogene. 2019;38(14):2516\u201332. https:\/\/doi.org\/10.1038\/s41388-018-0602-8.","journal-title":"Oncogene."},{"issue":"16","key":"1400_CR44","doi-asserted-by":"publisher","first-page":"e100836","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, W\u00fcst S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16):e100836. https:\/\/doi.org\/10.15252\/embj.2018100836.","journal-title":"EMBO J"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-021-01400-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-021-01400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T18:06:12Z","timestamp":1629569172000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-021-01400-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1400"],"URL":"https:\/\/doi.org\/10.1186\/s12943-021-01400-z","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"16 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was approved by the the Ethics Committee of FUSCC and Fudan University. All samples were obtained with informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors confirm their consent for publication the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"106"}}